The ACC/AHA pooled cohort risk equation significantly overestimated 5-year predicted risk of atherosclerotic cardiovascular disease events across sociodemographic groups.
The observed risk of abdominal aortic aneurysms increased with severity of psoriasis.
Oral estradiol therapy was associated with less progression of subclinical atherosclerosis when administered to women who were less 6 years past menopause.
Femoral atherosclerosis had a stronger association with cardiovascular risk factors and coronary calcium than carotid atherosclerosis.
Patients undergoing percutaneous coronary intervention may have increased culprit lesions and adverse plaque morphology caused by high on-treatment platelet reactivity.
Patients with cryptogenic stroke had a significantly higher proportion of intraplaque high-intensity signal in internal cartoid artery plaques ipsilateral to the side of infarction that was not seen in patients with strokes stemming from cardioembolism or small-vessel occlusion.
In a simple stenotic lesion, bioresorable scaffold implantation resulted in stable lumen dimensions, low restenosis, and low rates of major adverse cardiac events.
Hypoglycemia was associated with coronary artery calcium progression, but only in the standard therapy arm of the Veterans Affairs Diabetes Trial (vs the intensive therapy).
Researchers test ACC/AHA 2013 cholesterol guidelines to help predict patient risk of ASCVD.
Renal artery stenting did not improve stenosis severity, systolic blood pressure, or translesion pressure gradient when compared with medical therapy alone.
